Perioperative medicine & outcomes

Postoperative systemic inflammation after major abdominal surgery: patient‐centred outcomes

AnaesthesiaPublished Retrospective cohort study

Main finding · Persistent disability or death up to 90 daysResult — go to the resultAdjusted relative risk 1.76 95% CI 1.31–2.36

Authors' conclusion

Marked postoperative systemic inflammation was associated with increased risk of complications, poor quality of recovery and persistent disability or death up to 90 days after surgery.

Study context

Population
High-risk, elective, major abdominal surgery patients in the RELIEF trial, 47 centres in seven countries, May 2013 to September 2016
Participants
3,000 participants · 47 centres
Exposure
Quartile 4 vs Quartile 1
Outcome
Co-primary: persistent disability or death up to 90 days; quality of recovery (QoR-15) at days 3 and 30
Follow-up
90 days; days 3 and 30
Methodological detailsanalysis of prospectively collected RELIEF trial data, multicentre, multiple imputation
  • Analysis of prospectively collected RELIEF trial data
  • Multicentre
  • Multiple imputation

Main finding

Persistent disability or death up to 90 days · up to 90 days

Adjusted relative risk

1.76

95% CI 1.31–2.36

P < 0.001

Quartile 4 vs Quartile 1
adjusted RR 1.76 (95% CI 1.31–2.36); P < 0.001

As reported in the abstract

Observational data: associations, not effects.

Secondary outcomes

OutcomeDifference (95% CI)P value
Quality of recovery (QoR-15), risk-adjusted estimated medians (co-primary) · up to day 3Quartile 4 vs Quartile 1−14.4 (−17.38 to −10.71)P < 0.001
Quality of recovery (QoR-15), risk-adjusted estimated medians (co-primary) · day 30Quartile 4 vs Quartile 1−5.94 (−8.92 to −2.95)P < 0.001

Original publication

Postoperative systemic inflammation after major abdominal surgery: patient‐centred outcomes. Anaesthesia. Published 2 August 2023. doi:10.1111/anae.16104

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.